Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00109577 · ClinicalTrials.gov registry record · Phase 2
Clinical Trial of a Nutritional Supplement in Adults With Bipolar Disorder
A Phase 2 study, sponsored by University of Calgary.
- Terminated
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT00109577 is a Phase 2 study that was terminated before completion, run by University of Calgary. The registered enrollment target is 40 participants.
The verdict
NCT00109577, a Phase 2 study, was terminated before completion, sponsored by University of Calgary.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of the trial was to determine whether a 36-ingredient micronutrient supplement (primarily vitamins and minerals) is beneficial for the treatment of bipolar disorder, when studied under randomized and fully blinded conditions and compared to a placebo. The supplement is referred to as MCN36, because it contains 36 nutrients. Based on the preliminary research on this supplement, it is hypothesized that patients who take MCN36 for 8 weeks will experience improved mood stability relative to those who take the placebo. All participants must live EITHER in the vicinity of Calgary, Alberta, Canada, OR in the area of San Diego, California.
Interventions
- DRUG Placebo
- DRUG MCN36 (nutritional supplement)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2005-04 |
| Est. Completion | 2009-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00109577
The ClinicalTrials.gov registry entry for NCT00109577 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Calgary, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00109577 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00109577 about?
NCT00109577 is a clinical study titled "Clinical Trial of a Nutritional Supplement in Adults With Bipolar Disorder". The purpose of the trial was to determine whether a 36-ingredient micronutrient supplement (primarily vitamins and minerals) is beneficial for the treatment of bipolar disorder, when studied under randomized and fully blinded conditions and compared to a placebo. The supplement is referred to as MCN...
What is the current status of trial NCT00109577?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2005-04. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00109577?
The interventions under investigation include: Placebo (DRUG), MCN36 (nutritional supplement) (DRUG).
Who is sponsoring clinical trial NCT00109577?
This trial is sponsored by University of Calgary, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.